Changes in Circulating Procalcitonin Versus C-Reactive Protein in Predicting Evolution of Infectious Disease in Febrile, Critically Ill Patients

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Hoeboer, Sandra H ^a,b   Groeneveld, A B Johan ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BLOODSTREAM INFECTION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIAGNOSTIC VALUE; FEMALE; FEVER; HUMAN; INFECTION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTION; PROSPECTIVE STUDY; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; BACTEREMIA; BLOOD; COMPLICATION; CRITICAL ILLNESS; DISEASE COURSE; METABOLISM; MIDDLE AGED; MORTALITY; MULTIPLE ORGAN FAILURE; ORGAN DYSFUNCTION SCORE; PATHOLOGY; PROGNOSIS; SEPSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL;

ADULT; AGED; BACTEREMIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CRITICAL ILLNESS; DISEASE PROGRESSION; FEMALE; FEVER; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; ORGAN DYSFUNCTION SCORES; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SEPSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 84878809820     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065564     Document Type: Article

References (37)

1. Laupland KB, Shahpori R, Kirkpatrick AW, Ross T, Gregson DB, et al. (2008) Occurrence and outcome of fever in critically ill adults. Crit Care Med 36: 1531-1535.
2. Castelli GP, Pognani C, Cita M, Paladini R, (2009) Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma. Crit Care Med 37: 1845-1849.
3. Hoeboer SH, Alberts E, van den Hul I, Tacx AN, Debets-Ossenkopp YJ, et al. (2012) Old and new biomarkers for predicting high and low risk microbial infection in critically ill patients with new onset fever: a case for procalcitonin. J Infect 64: 484-493.
4. Meisner M, Tschaikowsky K, Palmaers T, Schmidt J, (1999) Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 3: 45-50.
5. Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, et al. (2003) Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 31: 1737-1741.
6. Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, et al. (2004) Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 8: R234-R242.
7. Povoa P, Coelho L, Almeida E, Fernandes A, Mealha R, et al. (2006) Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study. Crit Care 10: R63.
8. Rau BM, Frigerio I, Buchler MW, Wegscheider K, Bassi C, et al. (2007) Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study. Arch Surg 142: 134-142.
9. Tsangaris I, Plachouras D, Kavatha D, Gourgoulis GM, Tsantes A, et al. (2009) Diagnostic and prognostic value of procalcitonin among febrile critically ill patients with prolonged ICU stay. BMC Infect Dis 9: 213.
10. Lavrentieva A, Papadopoulou S, Kioumis J, Kaimakamis E, Bitzani M, (2012) PCT as a diagnostic and prognostic tool in burn patients. Whether time course has a role in monitoring sepsis treatment. Burns 38: 356-363.
11. Reynolds SC, Shorr AF, Muscedere J, Jiang X, Heyland DK, (2012) Longitudinal changes in procalcitonin in a heterogeneous group of critically ill patients. Crit Care Med 40: 2781-2787.
12. Su L, Han B, Liu C, Liang L, Jiang Z, et al. (2012) Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study. BMC Infect Dis 12: 157.
13. Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, et al. (2005) Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 171: 242-248.
14. Persson L, Soderquist B, Engervall P, Vikerfors T, Hansson LO, et al. (2005) Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia. Eur J Haematol 74: 297-303.
15. Viallon A, Guyomarc'h P, Guyomarc'h S, Tardy B, Robert F, et al. (2005) Decrease in serum procalcitonin levels over time during treatment of acute bacterial meningitis. Crit Care 9: R344-R350.
16. von Lilienfeld-Toal M, Schneider A, Orlopp K, Hahn-Ast C, Glasmacher A, et al. (2006) Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies. Support Care Cancer 14: 1241-1245.
17. Bruns AHW, Oosterheert JJ, Hak E, Hoepelman AIM, (2008) Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia. Eur Respir J 32: 726-732.
18. Lannergård A, Viberg A, Cars O, Karlsson MO, Sandstrom M, et al. (2009) The time course of body temperature, serum amyloid A protein, C-reactive protein and interleukin-6 in patients with bacterial infection during the initial 3 days of antibiotic therapy. Scand J Infect Dis 41: 663-671.
19. Crouzet J, Faucher JF, Toubin M, Hoen B, Estavoyer JM, (2011) Serum C-reactive protein (CRP) and procalcitonin (PCT) levels and kinetics in patients with leptospirosis. Eur J Clin Microbiol Infect Dis 30: 299-302.
20. Lacoma A, Rodriguez N, Prat C, Ruiz-Manzano J, Andreo F, et al. (2012) Usefulness of consecutive biomarkers measurement in the management of community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 31: 825-833.
21. Yentis SM, Soni N, Sheldon J, (1995) C-reactive protein as an indicator of resolution of sepsis in the intensive care unit. Intensive Care Med 21: 602-605.
22. Coelho L, Povoa P, Almeida E, Fernandes A, Mealha R, et al. (2007) Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course. Crit Care 11: R92.
23. Schmit X, Vincent JL, (2008) The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis. Infection 36: 213-219.
24. Hillas G, Vassilakopoulos T, Plantza P, Rasidakis A, Bakakos P, (2010) C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia. Eur Respir J 35: 805-811.
25. Theodorou VP, Papaioannou VE, Tripsianis GA, Panopoulou MK, Christophoridis EK, et al. (2012) Procalcitonin and procalcitonin kinetics for diagnosis and prognosis of intravascular catheter-related bloodstream infections in selected critically ill patients: a prospective observational study. BMC Infect Dis 12: 247.
26. Luyt CE, Guerin V, Combes A, Trouillet JL, Ayed SB, et al. (2005) Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med 171: 48-53.
27. Seligman R, Meisner M, Lisboa TC, Hertz FT, Filippin TB, et al. (2006) Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care 10: R125.
28. Lisboa T, Seligman R, Diaz E, Rodriguez A, Teixeira PJZ, et al. (2008) C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia. Crit Care Med 36: 166-171.
29. Coelho L, Salluh J, Soares M, Bozza F, Verdeal J, et al. (2012) Patterns of c-reactive protein RATIO response in severe community-acquired pneumonia: a cohort study. Crit Care 16: R53.
30. Gibot S, Cravoisy A, Kolopp-Sarda MN, Bene MC, Faure G, et al. (2005) Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med 33: 792-796.
31. Charles PE, Tinel C, Barbar S, Aho S, Prin S, et al. (2009) Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome. Crit Care 13: R38.
32. Povoa P, Teixeira-Pinto AM, Carneiro AH, (2011) C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study. Crit Care 15: R169.
33. Schuetz P, Muller B, Christ-Crain M, Stolz D, Tamm M, et al. (2012) Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev 9: CD007498.
34. Nijsten MW, Olinga P, The TH, de Vries EG, Koops HS, et al. (2000) Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 28: 458-461.
35. Calandra T, Cohen J, (2005) The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 33: 1538-1548.
36. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, et al. (2003) International Sepsis Definitions Conference. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med 29: 530-538.
37. de Kruif MD, Lemaire LC, Giebelen IA, Struck J, Morgenthaler NG, et al. (2008) The influence of corticosteroids on the release of novel biomarkers in human endotoxemia. Intensive Care Med 34: 518-522.